ventyxbio.com - VTYX Total Enterprise Value
Ventyx Biosciences (VTYX) minimizes production disruptions through an extensive network of external compound synthesis contractors. The specific nature of combating autoimmune pathologies makes the business resilient to market cycles and GDP fluctuations. This price chart reflects an Enterprise Value of 822.02. Furthermore, Ventyx Biosciences is expanding its scientific potential by forming alliances with academic centers to test anti-inflammatory agents.
Ventyx Biosciences (VTYX) - metric breakdowns and financial figures
- current price and projected stock value:
- issuer market value details:
- book capitalization data:
- company total debt and liquidity indicators:
Analysis of all company metrics:Ventyx Biosciences Inc.
This metric combines market capitalization with net debt, allowing investors to assess the actual cost of acquiring all assets without accounting for quarterly lags. For Ventyx Biosciences (VTYX) and its closed R&D patent loop, this metric reflects the market price for access to a unique biopharmaceutical ecosystem, as clearly captured by the historical EV trend in the GURU.Markets analytical terminal.
Competitors of Ventyx Biosciences (VTYX)
Aggregate Business Value ARGX (argenx N.V.)|BNTX: Real Price to Acquire Entire Company|Total Enterprise Value Abivax Pharma|ADMA (ADMA Biologics) - Real Price to Acquire Entire Company|Business Value PTGX|Total Company Value Immunovant|Kiniksa Pharmaceuticals, Ltd. - Full Business Value|Enterprise Value GRFS|ADPT (Adaptive Biotechnologies Inc.) - Value Adjusted for Debt and Cash|Enterprise Value CLDX (Celldex Therapeutics)|Enterprise Value auriniapharma.com AUPH|BCRX - Total Company Value|Value Adjusted for Debt and Cash VERA (Vera Therapeutics Inc)|Dianthus Pharma (DNTH) - Total Company Value|Real Price to Acquire Entire Company Pharvaris Pharma|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com|Real Price to Acquire Entire Company PGEN (Precigen)|PHAR (Pharming Group NV) - Value Adjusted for Debt and Cash|Enterprise Value NKTR (Nektar)|Company Buyout Price Upstream Pharma (UPB)|ZBIO - Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|Gossamer Bio (GOSS) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|Real Price to Acquire Entire Company SEPN|Enterprise Value Pieris Corp|Total Company Value Savara Inc. (SVRA)|rigel.com - Business Value|Enterprise Value ANAB (AnaptysBio)|Astria Therapeutics Inc (ATXS) - Total Enterprise Value|ENGN: Real Price to Acquire Entire Company|RAPT: Total Company Value|JBIO: Enterprise Value|Total Enterprise Value aclaristx.com (ACRS)|Total Company Value Kyverna Therapeutics, Inc.|Business Value TLSA (Tiziana Life Sciences Ltd.)|Real Price to Acquire Entire Company CABA (Cabaletta Bio, Inc)|Aggregate Business Value THTX|Avalo Therapeutics, Inc - Real Price to Acquire Entire Company|eledon.com (ELDN) - Total Enterprise Value|AGEN: Real Price to Acquire Entire Company|CLYM (Climb Bio Inc.) - Business Value|ZURA (Zura Bio) - Real Price to Acquire Entire Company|aTyr Pharmaceuticals - Value Adjusted for Debt and Cash|ADAG (Adagene Inc) - Enterprise Value|Total Company Value IMA|Enterprise Value STTK|Company Buyout Price equilliumbio.com|Total Company Value Connect Biopharma Holdings Limited CNTB|Immunic Therapeutics (IMUX) - Total Enterprise Value|ATRA - Total Company Value|Company Buyout Price InflaRx N.V. IFRX|XFOR: Enterprise Value|Real Price to Acquire Entire Company Adicet Bio, Inc.|CELU (Celularity Inc) - Enterprise Value|INmune Bio Corporation (INMB) - Company Buyout Price|Enterprise Value BRNS|KZR - Total Enterprise Value|Total Company Value SAB Biotherapeutics, Inc. SABS|AKTX: Business Value|Enlivex Therapeutics, Ltd. - Enterprise Value|Q32 Bio Inc. (QTTB) - Real Price to Acquire Entire Company|GOVX: Enterprise Value|Total Enterprise Value edesabiotech.com (EDSA)|Total Company Value iBio|Carisma Tx (CARM) - Company Buyout Price|Real Price to Acquire Entire Company XTLB (XTL Biopharmaceuticals, Ltd.)|Total Company Value BOLT (boltbio.com)|HCW Biologics - Real Price to Acquire Entire Company|Aggregate Business Value APVO (Aptevo Therapeutics, Inc.)|AIM: Real Price to Acquire Entire Company|Total Enterprise Value Aditxt|GRI (GRI Bio Corp) - Real Price to Acquire Entire Company|Business Value XRTX|Total Company Value Vyome Holdings Inc|revbiosciences.com - Full Business Value|Enterprise Value INDP|SCNI (Scinai Immunotherapeutics Ltd) - Value Adjusted for Debt and Cash|Enterprise Value CALI (CalciMedica)|Enterprise Value Affimed NV AFMD|ALLK - Total Company Value|Value Adjusted for Debt and Cash HOOK (HOOKIPA Pharma Inc.)|igmbio.com (IGMS) - Total Company Value|Real Price to Acquire Entire Company iTeos Therapeutics Inc|OCEA (Ocean Bio) - Enterprise Value|Enterprise Value TC BioPharm Ltd|Real Price to Acquire Entire Company THRD (Third Harmonic Bio)